| Authors: |
van der Doelen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Isaacsson Velho P; Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Medical Oncology, Hospital Moinhos de Vento, Porto Alegre, Brazil., Slootbeek PHJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Pamidimarri Naga S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Bormann M; Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, the Netherlands., van Helvert S; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Kroeze LI; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Antonarakis ES; Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Niven.Mehra@radboudumc.nl. |
